Skip to main content
Year archive

Hansoh Pharmaceutical Group Company Limited — 2021 filings

All 58 regulatory filings released by Hansoh Pharmaceutical Group Company Limited (3692) in 2021, sourced directly from the official regulator.

58 Filings
2021 Period
2021 filings (58)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME
Transaction in Own Shares
2021-12-31 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10383 TABLETS"
Regulatory Filings
2021-12-28 English
Terms of Reference of the Nomination Committee of the Board
Governance Information
2021-12-23 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2021-12-23 English
ESTABLISHMENT OF THE NOMINATION COMMITTEE AND APPOINTMENT OF COMMITTEE MEMBERS
Board/Management Information
2021-12-23 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF AMEILE IN FIRST LINE LOCALLY ADVANCED OR METASTATIC EGFR-MUTATED NON-SMALL CELL LUNG CANCER
Regulatory Filings
2021-12-16 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPROVAL OF "IBREXAFUNGERP TABLETS"
Regulatory Filings
2021-12-15 English
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH KEROS
Capital/Financing Update
2021-12-13 English
VOLUNTARY ANNOUNCEMENT - INCLUSION OF "TENOFOVIR AMIBUFENAMIDE TABLET" IN THE NATIONAL REIMBUREMENT DRUG LIST
Regulatory Filings
2021-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings
2021-12-01 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "FULVESTRANT INJECTION"
Regulatory Filings
2021-11-19 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME
Transaction in Own Shares
2021-11-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Regulatory Filings
2021-11-03 English
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH SILENCE THERAPEUTICS
Regulatory Filings
2021-10-15 English
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH OLIX PHARMACEUTICALS
Capital/Financing Update
2021-10-12 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10381 CAPSULES"
Regulatory Filings
2021-10-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings
2021-10-06 English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF "PEG SIHEMATIDE INJECTIONS" ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2021-10-04 English
INTERIM REPORT 2021
Interim / Quarterly Report H1 2021
2021-09-23 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2021-09-06 English
ANNOUNCEMENT IN RELATION TO RESIGNATION OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2021-09-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Regulatory Filings
2021-09-03 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021
Interim / Quarterly Report H1 2021
2021-08-26 English
DATE OF BOARD MEETING
Regulatory Filings
2021-08-16 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Regulatory Filings
2021-08-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Regulatory Filings
2021-08-04 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2020
Environmental & Social Information
2021-07-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
Share Issue/Capital Change
2021-07-07 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2021-06-28 English
ESTABLISHMENT OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE AND APPOINTMENT OF COMMITTEE MEMBERS
Environmental & Social Information
2021-06-28 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "TENOFOVIR AMIBUFENAMIDE TABLETS"
Regulatory Filings
2021-06-23 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "LURASIDONE HYDROCHLORIDE TABLETS"
Regulatory Filings
2021-06-11 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10365 CAPSULES"
Regulatory Filings
2021-06-04 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "ERLOTINIB HYDROCHLORIDE TABLETS"
Regulatory Filings
2021-06-04 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 3, 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
Share Issue/Capital Change
2021-06-02 English
VOLUNTARY ANNOUNCEMENT - RESULTS OF THE PHASE III AENEAS STUDY OF AMEILE AS THE FIRST-LINE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC EGFR-MUTATED NON-SMALL CELL LUNG CANCER WILL BE PUB
Regulatory Filings
2021-05-20 English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF AMEILE IN FIRST LINE EGFR-MUTATED NON-SMALL CELL LUNG CANCER ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2021-05-13 English
VOLUNTARY ANNOUNCEMENT - FDA TENTATIVE APPROVAL OF "BORTEZOMIB FOR INJECTION"
Regulatory Filings
2021-05-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Share Issue/Capital Change
2021-05-06 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 3, 2021
AGM Information
2021-04-27 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-27 English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2021-04-27 English
ANNUAL REPORT 2020
Annual Report FY 2020
2021-04-27 English
Next Day Disclosure Return
Share Issue/Capital Change
2021-04-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Share Issue/Capital Change
2021-04-07 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "LENALIDOMIDE CAPSULE"
Regulatory Filings
2021-04-01 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020
Annual Report FY 2020
2021-03-30 English
DATE OF BOARD MEETING
Regulatory Filings
2021-03-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Share Issue/Capital Change
2021-03-03 English
VOLUNTARY ANNOUNCEMENT - AMEILE PHASE III STUDY MET ITS PRIMARY ENDPOINT IN THE FIRST-LINE TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC EGFR-MUTATED NON-SMALL CELL LUNG CANCER
Regulatory Filings
2021-02-21 English
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH SCYNEXIS
Capital/Financing Update
2021-02-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Share Issue/Capital Change
2021-02-03 English
PUBLICATION OF OFFERING CIRCULAR - HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED - US$600 MILLION ZERO COUPON CONVERTIBLE BONDS DUE 2026
Capital/Financing Update
2021-01-25 English
NOTICE OF LISTING ON THE STOCK EXCHANGE OF HONG KONG LIMITED - HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED - US$600 MILLION ZERO COUPON CONVERTIBLE BONDS DUE 2026
Capital/Financing Update
2021-01-24 English
COMPLETION OF THE ISSUE OF US$600 MILLION ZERO COUPON CONVERTIBLE BONDS DUE 2026
Capital/Financing Update
2021-01-22 English
PROPOSED ISSUE OF US$600 MILLION ZERO COUPON CONVERTIBLE BONDS DUE 2026
Capital/Financing Update
2021-01-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Share Issue/Capital Change
2021-01-05 English